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ABSTRACT The osteoclast, the multinucleated giant cell of bone, is derived from circulating blood
cells, most likely monocytes. Evidence has accrued that is consistent with the hypothesis that the
recruitment of monocytes for osteoclast development occurs by chemotaxis. In the present study, we
have examined the chemotactic response of human peripheral blood monocytes and related poly-
morphonuclear leucocytes to three constituents of bone matrix: peptides from Type I collagen, a2HS
glycoprotein, and osteocalcin (bone gla protein) . The latter two substances are among the major
noncollagenous proteins of bone and are uniquely associated with calcified connective tissue.
In chemotaxis assays using modified Boyden chambers, Type I collagen peptides, a2HS glycoprotein,
and osteocalcin evoke a dose-dependent chemotactic response in human monocytes. No chemotaxis
is observed in PMNs despite their ontogenetic relationship to monocytes and their documented
sensitivity to a broad range of other chemical substances. Our observations are consistent with the
view that osteoclast precursors (monocytes) are mobilized by chemotaxis, and suggest that the
chemoattractants responsible for this activity are derived from the bone matrix or, in the case of
collagen and osteocalcin, directly from the osteoblasts which produce them .
Osteoclasts are multinucleated giant cells that originate through
the fusion of uninucleated precursors (l-4). Within the past
five years, substantial evidence has accumulated which indi-
cates that these precursors are derived from hematopoietic stem
cells located in bone marrow, and that they are carried to sites
of incipient or active bone resorption by the blood vascular
system (5-7). The available evidence strongly suggests that this
precursor cell either is a mononuclear phagocyte (i.e., a mac-
rophage or monocyte) or is derived from the same progenitor
which gives rise to mononuclear phagocytes (8-11).
It has been proposed that monocytes are recruited from the
circulation to sites of osteoclast differentiation by chemotaxis
(12-14). This suggestion follows from the observation that
mononuclear phagocytes exhibit directional migration when
placed in a gradient of conditioned medium collected from
cultures of resorbing bone rudiments (15) and are chemotacti-
cally attracted to a partially purified factor isolated from
neonatal mouse bone (16). Clearly, both conditioned media
and bone extracts are likely to contain a number of factors
capable of eliciting a chemotactic response in cells as broadly
sensitive to environmental stimulation as mononuclear phag-
ocytes (17), including some which are probably not present
under normal conditions of bone turnover. However, the os-
teoclast is a cell specifically associated with bone and, conse-
quently, it seems reasonable to suppose that, if chemotaxis is
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involved in mobilizing osteoclast precursors, the chemoattrac-
tants originate from the cells or the extracellular matrix which
characterize this tissue.
Mature bone matrix is a complex, highly mineralized (-65%
dry weight) material built upon a structural framework ofType
I collagen (-25-30%) and containing a comparatively small
number of noncollagenous proteins and glycoproteins (<5%)
(18). Two of the better characterized of the latter proteins are
a2HS glycoprotein and osteocalcin. a2HS glycoprotein is syn-
thesized in the liver and is selectively accumulated, relative to
other plasma proteins, in bone and other mineralized tissues
(19, 20). Osteocalcin (bone gla protein) is similarly associated
with a range of mineralized tissues but, at least in bone, appears
to be synthesized locally, probably by osteoblasts (21-23). Both
osteocalcin and a2HS glycoprotein have been implicated in the
mineralization process (18, 24).
In the present study, we have attempted to estabish whether
a2HS glycoprotein, osteocalcin, and mammalian collagenase-
produced fragments of Type I collagen might serve as the
chemoattractive agents involved in the recruitment ofosteoclast
precursors. It has already been shown that peripheral mono-
cytes respond to bacterial enzyme digests of Type I collagen
(17) and, in fact, to dipeptides and tripeptides containing
glycine and proline, amino acids closely identified with the
primary structure of collagen (25). Our data demonstrate that
227human peripheral monocytes respond chemotactically to osteo-
calcin and a2HS glycoprotein as well as to collagen peptides
derived through the action of mammalian collagenase . Poly-
morphonuclear leucocytes (PMNs) do not exhibit these re-
sponses despite their known sensitivity to other chemotactic
stimuli (26) and their ontogenetic relationship to monocytes
(27-29).
MATERIALS AND METHODS
Cell Isolation
Mononuclear cells and PMNs were separated from freshly drawn, heparinized
human blood according to the Ficoll-Hypaque density gradient technique (30) .
The cells were washed in Eagle's minimal essential medium with L-glutamine
(a-MEM [alpha modification] ; KC Biological, Lenexa, Kans.) and were sus-
pendedto a final concentration of2.5 x 108 mononuclear cellsor 1 .5 x 106 PMNs
per milliliter in a-MEM or in a-MEM supplemented with 10% heat-inactivated
(60°C for45 min) fetal calfserum (a-10 HI) . 0.7 ml of cell suspension was then
pipetted into the upper compartment of modified Boyden chamber ; (AHLCO
Mfg . Co., Southington, Conn.).
Chemotaxis Assay
The chemotactic activities of osteocalcin, a 2HS glycoprotein, and Type I
collagen peptides were determined by use of the double-membrane technique
developed by Campbell (31) . The lower membrane was cellulose acetate, pore
size 0.45 )Am (Millipore Corp., Bedford, Mass .) ; the upper membrane (facing the
cells) was polycarbonate (Nucleopore Corp., Pleasanton, Calif.), pore size either
2 tam forPMN assays or 5 Am for monocytes. The chambers were prepared in
triplicate for each variable and were incubated in humidified air at 37°C . After
60 min (for PMNs) or 120 min (for monocytes), the membrane pairs were fixed
in isopropanol, stained withhematoxylin, and mountedon slides. Theslides were
then coded, randomized, and read without reference to the code . Chemotactic
activity was quantified on the basis ofthe number ofcells located at the interface
between the two membranes and falling within the boundaries of an eyepiece
grid at x 400 magnification . Five random grids were read for each membrane
pair. The resultswere expressed as the meannumberofcells/grid t SE, for each
set of triplicate samples, and were corrected for random cell migration as
determined from scoring control chambers having only medium in the lower
compartment . Statistical analysis was made using Student's t test of means.
The positive control in all experiments was C5-derived chemotactic activity
(Cs,), prepared from zymosan-activated human serum (a gin from Dr. D.
Kreutzer, University of Connecticut, Farmington, Conn .) and standardized for
50% maximum chemotactic activity (ED.) against human monocytes (32, 33) .
Twice the ED ., in 25 pl, was added to the lower compartment of each positive
control chamber. Both the test substances and the Cs. were diluted to the desired
concentration in eithera-MEM ora-10 HI. Thesemediawere supplementedwith
100,000 U/liter penicillin and 100mg/literstreptomycin, and were filter-sterilized
before use.
Preparation of Test Materials
Type I collagen peptides ("7,500 mean mot wt) were produced by digesting
native guinea pig skin collagen with purified mammalian collagenase and were
generously provided by Dr. J . Jeffrey (Washington University School of Medi-
cine, St . Louis, Mo .) . Human axHS glycoprotein (49,000 mol wt) was isolated
from human serum using the purification sequence described by Triftt et al .
(20) and was kindly prepared for us by Dr. Triffitt (Medical Research Council
Bone Research Laboratory, Oxford, England) . Osteocalcin (5,670 mol wt) was
extractedfromlyophilized chicken bone with EDTAand purified by gel filtration
and ion-exchange chromatography according to the methods described by
Hauschka and collaborators (21) . This substance, which was determined to be
free of collagen contamination, was provided by Dr . Hauschka (Harvard Uni-
versity School of Dental Medicine, Cambridge, Mass.).
RESULTS
Human peripheral monocytes respond chemotactically to col-
lagen peptides produced by the action ofmammalian collagen-
ase . The magnitude of the response is dose dependent within
the range tested (6.25-100 tig/ml) and is optimal at 12.5-25
txg/ml (1 .7-3.3 X 10-e M) (Fig. 1 a) . At these latter concentra-
tions, collagen peptides are 40-50% as effective as the positive
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FIGURE 1
￿
(a and b) The chemotactic response of human peripheral
monocytes to peptides from Type 1 Collagen . Note that monocytes
are optimally responsive to collagen peptides at concentrations of
12 .5 and 25 14g/ml (1 .7-3 .3 X 10-s M) (a) and that the response is
abolished in the absence of a gradient (b) . The "fractions" used in
labeling the abscissa indicate the location of the test substance in
the Boyden chamber (top [upper] or bottom [lower] compartment)
and its concentration in ,ug/ml . Striped bars denote chambers con-
taining test material ; open bars, chambers containing the positive
control substance, C5a . Values are expressed as net cells/HPF (high-
power field) and are plotted t SEM .
control substance, C5a . Net migration is not observed when the
gradient is abolished by placing collagen peptides in both
compartments of the Boyden chamber or exclusively in the
cell-containing, upper compartment (Fig . 1 b) . Similarly, no
chemotaxis is observed when mammalian collagenase alone is
used as a test substance (data not shown) .
Purified osteocalcin also promotes a dose-dependent chem-
otactic response in monocytes (Fig. 2a). This response, elicited
over the range of 6.25-100 tag/ml, is optimal at 12.5-25 ug/ml
(2.2-4.3 X 10-6 M) . Chemotaxis fails to occur ifthe osteocalcin
is placed in both compartments of the Boyden chamber or if
the protein is present only in the upper compartment (Fig. 2 b).
(In fact, in the particular experiment illustrated in Fig . 26 the
presence ofosteocalcin in the upper compartment significantly
inhibited (P < 0.01) the net migration of cells into the mem-
brane). Neither osteocalcin nor collagen peptides used over the
same concentration range evoke a chemotactic response in
PMNs (data not shown) .W
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(a and b) The chemotactic response of human peripheral
monocytes to osteocalcin . Note that the cells show significant
directed migration to osteocalcin at concentrations ranging from
6.25 to 100 flg/ml and that they are optimally responsive at 12 .5 and
25 tLg/ml (2.2-4 .3 X 10-s M) . Note also that a net positive migration
is only observed when the chemoattractant is present in the lower
(bottom) compartment of the Boyden chamber (b) .
The limited availability of purified a2HS glycoprotein pre-
cluded our fully assessing the chemotactic nature of this com-
pound . However, the results, to date, demonstrate that the
glycoprotein does elicit the increased migration of monocytes
under conditions identical to those employed in collagen pep-
tide and osteocalcin assays, and is effective at comparable
concentrations, i .e ., between 6.25 and 50 Itg/ml (1 .3 X 10-7 to
1 .02 X 10-s M) (Fig. 3) .
Osteoclast development occurs under physiological conditions
at sites within the skeleton which are undergoing (or about to
undergo) bone resorption . The first step in this process, the
mobilization of precursor cells, appears to result from the
chemotaxis of mononuclear phagocytes (15, 16), cells known
to exhibit directional migration in response to a variety of
chemical agents (17). Since osteoclast development is a tissue-
specific phenomenon and is generally linked to other events
associated with normal bone turnover, it follows that the
chemotactic factor (or factors) responsible for mobilizing the
precursor cells should exhibit a similar tissue specificity and
become available as a consequence of the processes of bone
formation or resorption .
Because the organic constituents of bone matrix largely
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FIGURE 3
￿
The in . vitro migration of human peripheral monocytes
in a gradient of a2HS glycoprotein . Note that the magnitude of the
response to this serum glycoprotein and the effective concentration
(1 .3 X 10-7 to 1 .02 X 10-6 M) are similar to those observed with
collagen peptides and osteocalcin .
define the microenvironment in which osteoclasts are formed,
these constituents would clearly fulfill the "geographic" re-
quirement for chemoattractants which might be involved in
the recruitment of osteoclast precursor cells . In addition, such
substances would become available as recruiting agents when
bone matrix is broken down during osteolysis or, in the case of
matrical components produced in situ, as a direct result of
secretion by osteoblasts lining the bone surface . In fact, as
documented below, the bone literature contains reports con-
sistent with both modes of chemoattractant release.
When bone is stimulated to resorb, by any of a number of
chemical agents, the osteoclast population characteristically
responds with a burst of resorptive activity by extant cells
followed, after a lag period of several hours, by the generation
of new, and often larger, osteoclasts (34-37) . During this lag
period, the mineral component ofthe bone matrix is mobilized
and, along with it, a2HS glycoprotein, osteocalcin, and, prob-
ably, collagen . These substances would then serve to attract
monocytes (precursor cells) to sites ofosteoclast differentiation .
In support ofthis possible mechanism ofprecursor recruitment,
we note that demineralization is the first phase of bone resorp-
tion (38), and that both a 2HS glycoprotein and osteocalcin are
released from bonewhen the mineral component ofthe matrix
is removed (19, 24) . We also note that urinary excretion of
hydroxyproline (presumably derived from the degradation of
bone collagen) is elevated during periods of bone resorption
(39) and that plasma levels of osteocalcin (bone gla protein)
are increased in bone disease characterized by high bone
turnover (40) .
There are other circumstances, such as those encountered in
embryonic and fetal life, where osteoclasts appear de novo, in
the absence of any apparent, prior resorptive activity . Here, it
seems reasonable to speculate that the secretion of soluble
chemoattractive matrix constituents by osteoblasts is responsi-
ble for attracting osteoclast precursor cells . In support of this
proposition, we note that osteoblast-derived osteogenic sar-
coma cells synthesize and release osteocalcin (bone gla protein)
in vitro (41), and that the level of synthesis of this compound
can be significantly increased by exposing the cells to parathy-
roid hormone (PTH) (42) . In addition, the serum level of bone
gla protein is increased in rats after the injection of
1,25(OH)2D3 (43) . Finally, we call attention to the growing
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tion in vitro via receptors located on osteoblasts rather than
osteoblasts (44).
The results of the present study demonstrate that monocytes
respond chemotactically to osteocalcin, to a2HS glycoprotein,
and to Type I collagen peptides produced through the action
of a purified mammalian collagenase. By contrast, PMNs do
not respond to either osteocalcin or collagen peptides despite
the fact that they are derived from the same hematopoietic
stem cell as monocytes (27-29) and are chemotactically sensi-
tive to a broad spectrum of other substances (25). These
findings support the hypothesis that chemotaxis plays a major
role in therecruitment ofosteoclast precursorcells, andsuggest
that the likely sources for the relevant chemoattractive agents
arethe bone matrix and the osteoblast.
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